{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T04:29:58Z","timestamp":1683952198684},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Henan Province Chinese Medicine Special Research Project","award":["2019JDZX2031"],"award-info":[{"award-number":["2019JDZX2031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The hypereosinophilic syndrome (HES) is a group of rare blood disorders characterized by persistent eosinophilia and damage to multiple organs. HES can be either primary, secondary or idiopathic. Secondary HES are commonly caused by parasitic infections, allergic reactions or cancer. We described a pediatric case of HES associated with liver damage and multiple thrombi.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case summary<\/jats:title>\n                <jats:p>A 12-year-old boy with eosinophilia was complicated with severe thrombocytopenia, liver damage, portal vein, splenic vein, and superior mesenteric vein thromboses. The thrombi recanalized after treatment with methylprednisolone succinate and low molecular weight heparin. No side effects appeared after 1-month.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Corticosteroids should be used at an early stage of HES to prevent further damage to vital organs. Anticoagulants should be recommended only in cases with thrombosis which should be actively screened as a part of evaluation of end organ damage.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-023-04014-0","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:02:03Z","timestamp":1683864123000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pediatric hypereosinophilic syndrome associated with liver damage, portal vein, splenic vein and superior mesenteric vein thromboses: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Hai-Tao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Bin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Xia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian-Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"4014_CR1","doi-asserted-by":"crossref","unstructured":"Farruggia P, Giugliano E, Russo D, Trizzino A, Lorenzatti R, Santoro A, D\u2019Angelo P: FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome in childhood: a case report and review of literature. J Pediatr Hematol Oncol 2014, 36(1):e28-e30.","DOI":"10.1097\/MPH.0b013e31827e6386"},{"key":"4014_CR2","doi-asserted-by":"crossref","unstructured":"Butt NM, Lambert J, Ali S, Beer PA, Cross NC, Duncombe A, Ewing J, Harrison CN, Knapper S, McLornan D et al: Guideline for the investigation and management of eosinophilia. Br J Haematol 2017, 176(4):553\u2013572.","DOI":"10.1111\/bjh.14488"},{"key":"4014_CR3","doi-asserted-by":"crossref","unstructured":"Klion A: Hypereosinophilic syndrome: current approach to diagnosis and treatment. ANNU REV MED 2009, 60:293\u2013306.","DOI":"10.1146\/annurev.med.60.062107.090340"},{"key":"4014_CR4","doi-asserted-by":"crossref","unstructured":"Hwang JW, Kim H, Cho SW, Shin YC, Kim HS, Cho YJ, Kwak JJ: Idiopathic hypereosinophilic syndrome with intracardiac atypical linear-shaped and floating thrombus presenting as embolic cerebral infarction. J Cardiol Cases 2021, 23(5):193\u2013197.","DOI":"10.1016\/j.jccase.2020.10.015"},{"key":"4014_CR5","doi-asserted-by":"crossref","unstructured":"Lin J, Huang X, Zhou W, Zhang S, Sun W, Wang Y, Ren K, Tian L, Xu J, Cao Z et al: Thrombosis in the portal venous system caused by hypereosinophilic syndrome: A case report. Medicine (Baltimore) 2018, 97(48):e13425.","DOI":"10.1097\/MD.0000000000013425"},{"key":"4014_CR6","doi-asserted-by":"crossref","unstructured":"Gao SJ, Wei W, Chen JT, Tan YH, Yu CB, Litzow MR, Liu QJ: Hypereosinophilic syndrome presenting with multiple organ infiltration and deep venous thrombosis: A case report and literature review. Medicine (Baltimore) 2016, 95(35):e4658.","DOI":"10.1097\/MD.0000000000004658"},{"key":"4014_CR7","unstructured":"Xu W, Guo W, Yang T: [Hypereosinophilic syndrome with first presentation of pulmonary embolism and extensive venous thrombosis: a case report and literature review]. Zhonghua Jie He He Hu Xi Za Zhi 2015, 38(12):912\u2013917."},{"key":"4014_CR8","doi-asserted-by":"crossref","unstructured":"Cogan E, Roufosse F: Clinical management of the hypereosinophilic syndromes. EXPERT REV HEMATOL 2012, 5(3):275\u2013289, 290.","DOI":"10.1586\/ehm.12.14"},{"key":"4014_CR9","doi-asserted-by":"crossref","unstructured":"Ogbogu PU, Bochner BS, Butterfield JH, Gleich GJ, Huss-Marp J, Kahn JE, Leiferman KM, Nutman TB, Pfab F, Ring J et al: Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol 2009, 124(6):1319\u20131325.","DOI":"10.1016\/j.jaci.2009.09.022"},{"key":"4014_CR10","doi-asserted-by":"crossref","unstructured":"Wechsler ME, Fulkerson PC, Bochner BS, Gauvreau GM, Gleich GJ, Henkel T, Kolbeck R, Mathur SK, Ortega H, Patel J et al: Novel targeted therapies for eosinophilic disorders. J Allergy Clin Immunol 2012, 130(3):563\u2013571.","DOI":"10.1016\/j.jaci.2012.07.027"},{"key":"4014_CR11","doi-asserted-by":"crossref","unstructured":"Klion AD: How I treat hypereosinophilic syndromes. BLOOD 2015, 126(9):1069\u20131077.","DOI":"10.1182\/blood-2014-11-551614"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04014-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-023-04014-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04014-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T04:04:28Z","timestamp":1683864268000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-023-04014-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":11,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4014"],"URL":"https:\/\/doi.org\/10.1186\/s12887-023-04014-0","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]},"assertion":[{"value":"21 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial relationships relevant to this article to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial disclosure"}},{"value":"No potential conflict of interest was reported by the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was approved by the Ethical Committee of the First Affiliated Hospital of Henan University of Chinese Medicine (China). This case report was written in accordance with the Health Insurance Portability and Accountability Act (HIPAA) regulations. The patient\u2019s parents\/legal guardians provided the informed consent for data collection and publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Consent for publication was obtained from the participant\u2019s mother, Zhao Jing.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"233"}}